Auto-generated: February 12 2012 07:35 AM GMT-8

402
Stars
Star This?

Source: DGNews  |  Posted 8 years ago

FDA Grants Orphan Drug Designation For Fidelin (DHEA), Treatment For Adrenal Insufficiency

    Tags:

Read/Add Comments | Email This | Print This

MONTREAL, QC -- August 29, 2003 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that it has received orphan drug designation for Fidelin

402
Stars
Star This?  Yes / No

  • Comments

    To post a comment, please sign in or register as a physician.
 

Terms of Use |  Privacy Policy

© All Content Copyright 1995 - 2012 Doctor's Guide Publishing Limited. All Rights Reserved.

Sign InSign In
inst val